Good product pipeline, attractive valuation makes Bayer CropScience a bullish bet: Sudip Bandyopadhyay

In a chat with ET Now, Sudip Bandyopadhyay, President, Destimoney Securities, shares his views on Bayer CropScience. Excerpts:

ET Now: What is your view on the midcap stocks?
Sudip Bandyopadhyay: I am extremely bullish on is Bayer CropScience. It is leading in agrochemical field. It has great parentage, great balance sheet, excellent product pipeline, attractive valuation. It can give 20 per cent plus return in about a year’s time.